We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 60.50 | 60.00 | 61.00 | 60.50 | 60.50 | 60.50 | 14,770 | 07:44:37 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Computers | 1.03M | -2.92M | -0.2188 | -2.77 | 8.07M |
Date | Subject | Author | Discuss |
---|---|---|---|
14/1/2020 08:56 | What do you make of this tweet especially the highlighted part? Crucially, within this partnership, CADRAN is provided under licence (with Feedback PLC retaining all associated IP) so represents a low cost revenue stream which can parallel the roll out and success of #Bleepa without directing resource away from it Is it going to be another SAAS model? Is Bleepa a success yet? | ged5 | |
14/1/2020 06:57 | I'm not getting some posts that's why I've found and posted sorry. But I cant see that. | demonboy | |
14/1/2020 00:57 | Demonboy - See post #4279. Specifically - | lr2 | |
14/1/2020 00:41 | https://www.google.c | demonboy | |
13/1/2020 22:47 | Nice work LR2. Texrad is alive and well after all. Also, not a bad announcement this morning from the company, certainly warranted a few percentage rise but hey ho this is Aim! | petekand | |
13/1/2020 16:54 | You're welcome Davy. Hope all is well with you. Ged, your guess is as good as mine about an announcement. Would be nice if they did. Would have to assume the Imaging Engineering RNS has more importance than we originally thought if they do not. Surely must be financially beneficial to the company in some way. Another income stream I guess. | lr2 | |
13/1/2020 16:48 | Ged, they aren’t getting it free! | ducatiman | |
13/1/2020 16:46 | Good question Duc - not sure of answer. Posed the same to StoneChecker personnel in the past and they said "It don't matter" or words to that effect. Then, again, they'd say anything for a quiet life. | lr2 | |
13/1/2020 16:45 | Thanks LR2. Do you think the company will make an announcement about this use of TexRAD? Will FDBK receive any licencing fee? | ged5 | |
13/1/2020 16:42 | Now that's what I'm talking about! Thanks LR2 | davydoo | |
13/1/2020 16:40 | I did not LR2 but this is why we invested here in the first place! Question:- where do they stand when Texrad does not have FDA approval? Edit, or like stone checker, it is not needed? | ducatiman | |
13/1/2020 16:28 | Did you notice it was a Berkshire Hathaway company that posted it? That bloke Warren's a clever old so-and-so. | lr2 | |
13/1/2020 16:23 | Indeed not LR2. | ducatiman | |
13/1/2020 16:22 | Not just a pretty face, Duc. | lr2 | |
13/1/2020 16:19 | Great find LR2!!!! | ducatiman | |
13/1/2020 16:10 | And now we have - Breakthrough Radiomic Technology Patent Issued to Imaging Endpoints "The signature is derived from processing mammography data using a Quantitative Textural Analysis™ platform (TexRAD); generating respective histograms and related quantitative metrics, and performing logistical regression to yield a model predictive signature." | lr2 | |
13/1/2020 15:41 | https://www.proactiv | demonboy | |
13/1/2020 15:38 | I thought this was more pertinent to today's announcement:- Crucially, within this partnership, CADRAN is provided under licence (with Feedback PLC retaining all associated IP) so represents a low cost revenue stream which can parallel the roll out and success of #Bleepa without directing resource away from it | ged5 | |
13/1/2020 15:36 | https://www.med-tech | demonboy | |
13/1/2020 15:24 | https://www.homecare | demonboy | |
13/1/2020 15:19 | https://twitter.com/ | demonboy | |
13/1/2020 14:04 | The major factors for the growth of the fluoroscopy devices market include the rising demand for minimally-invasive surgeries, growing geriatric population, prevalence of chronic diseases, and increasing use of fluoroscopy in pain management. North America is holds a major share for the fluoroscopy devices market, and is expected to show a similar trend over the forecast period, without significant fluctuations. The United States has the largest installed base of fluoroscopes in the world. An estimated 4-10 million interventional pain procedures are performed annually in the country, with at least 50% of those performed under fluoroscopy. | ged5 | |
13/1/2020 12:44 | A small number of initial installations have already been performed by Imaging Engineering and the first license fees have now been received by Feedback Medical, the company said. | demonboy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions